Mixed-ligand ruthenium polypyridyl complexes as apoptosis inducers in cancer cells, the cellular translocation and the important role of ROS-mediated signaling

2014 ◽  
Vol 43 (45) ◽  
pp. 17017-17028 ◽  
Author(s):  
Zhennan Zhao ◽  
Zuandi Luo ◽  
Qiong Wu ◽  
Wenjie Zheng ◽  
Yanxian Feng ◽  
...  

Ruthenium complexes enter cancer cells through TfR-mediated endocytosis and translocate to the mitochondria, where they activate ROS-mediated apoptosis.

Metallomics ◽  
2014 ◽  
Vol 6 (8) ◽  
pp. 1480-1490 ◽  
Author(s):  
Zuandi Luo ◽  
Lianling Yu ◽  
Fang Yang ◽  
Zhennan Zhao ◽  
Bo Yu ◽  
...  

Ruthenium polypyridyl complexes inhibit cancer growth by targeting TrxR and promote the intracellular ROS generation, ultimately triggering mitochondria-mediated cell apoptosis.


2010 ◽  
Vol 49 (14) ◽  
pp. 6366-6368 ◽  
Author(s):  
Tianfeng Chen ◽  
Yanan Liu ◽  
Wen-Jie Zheng ◽  
Jie Liu ◽  
Yum-Shing Wong

1999 ◽  
Vol 38 (26) ◽  
pp. 6320-6322 ◽  
Author(s):  
Yuan-jun Hou ◽  
Pu-hui Xie ◽  
Bao-wen Zhang ◽  
Yi Cao ◽  
Xu-rui Xiao ◽  
...  

2003 ◽  
Vol 68 (8) ◽  
pp. 1467-1487 ◽  
Author(s):  
Wesley R. Browne ◽  
Frances Weldon ◽  
Adrian Guckian ◽  
Johannes G. Vos

The syntheses and characterisation of a series of mononuclear and dinuclear ruthenium polypyridyl complexes based on the bridging ligands 1,3-bis-[5-(2-pyridyl)-1H-1,2,4-triazol-3-yl]benzene, 1,4-bis-[5-(2-pyridyl)-1H-1,2,4-triazol-3-yl]benzene, 2,5-bis-[5-(2-pyridyl)-1H-1,2,4-triazol-3-yl]thiophene, 2,5-bis-[5-pyrazinyl-1H-1,2,4-triazol-3-yl]thiophene are reported. Electrochemical studies indicate that in these systems, the ground state interaction is critically dependent on the nature of the bridging ligand and its protonation state, with strong and weak interactions being observed for thiophene- and phenylene-bridged complexes, respectively.


2018 ◽  
Vol 190 ◽  
pp. 03012
Author(s):  
Charles W. Stark ◽  
M. Rammo ◽  
K. Petritšenko ◽  
J. Pahapill ◽  
A. Mikhaylov ◽  
...  

Quantitative two-photon absorption (2PA) cross section and 2PA spectrum measurements were used to determine the molecular electric dipole change in the metal-to-ligand charge-transfer transition of ruthenium(II) tris-complexes of 2,2’-bipyridine ([Ru(bpy)3]2+) and 1,10-phenanthroline ([Ru(phen)3]2+) in several solvents.


2012 ◽  
Vol 65 (9) ◽  
pp. 1325 ◽  
Author(s):  
Nathan L. Kilah ◽  
Eric Meggers

Sixty years ago, the Australian chemist Francis P. Dwyer pioneered the use of ruthenium polypyridyl complexes as biologically active compounds. These chemically inert and configurationally stable complexes revealed an astonishing range of interesting biological activities, such as the inhibition of the enzyme acetylcholinesterase, anti-cancer activity in vivo, and bacteriostatic/bacteriocidal action. This review commemorates the sixtieth anniversary of Dwyer and co-workers’ landmark 1952 publication, summarises their broader achievements in biological inorganic chemistry, and discusses the contribution of this work to the development of modern biological and medicinal inorganic chemistry.


Sign in / Sign up

Export Citation Format

Share Document